Destiny Pharma PLC undervalued compared to peers, suggests finnCap
"Phase 3 trial design is due to be finalised in H1 2022, which should catalyse partnering discussions.“ Destiny Pharma’s 29021...
"Phase 3 trial design is due to be finalised in H1 2022, which should catalyse partnering discussions.“ Destiny Pharma’s 29021...
Hydrogen Utopia International PLC (LON:HUI), to join Access Segment of the Aquis Stock Exchange. The company aims to become one...
Orderbook values of new customer contracts signed in the first two months of the year are 93% ahead of the...
Inspired PLC (AIM:INSE) chief executive Mark Dickinson talks to Proactive London about the bumper results announced today, how it’s helping...
Inspired PLC (AIM:INSE) is a buy with broker Peel Hunt after the company confirmed its strong start to the year. The analysts...
After the deluge in recent weeks the results flow starts to ease a little on Thursday Thursday's announcements will be about...
Inspired PLC (AIM:INSE), the energy consultant, said that it has already started to take mitigating action in the event Russian...
Destiny Pharma PLC (AIM:DEST) presenting at the Proactive One2One Virtual Forum - 17th March 2022 Destiny Pharma PLC (AIM:DEST) (Destiny...
Other companies reporting during the week include Carnival, CVS, Halma, Saga, Smiths Group, Ultra Electronics and Wood Group With Rishi...
Companies are misleading consumers (and investors), the report found, calling for governments and regulatory bodies to "step up and put...